Premium
IC‐P‐088: Effects of 12 months of treatment with the PPAR γ agonist rosiglitazone on brain glucose metabolism in Alzheimer's disease: A 18 F‐FDG PET study
Author(s) -
Rabiner Eugenii A.,
Tzimopoulou Sofia,
Cunningham Vincent J.,
Jeter Barbara,
ZvartauHind Marina,
Castiglia Mary,
Mistry Praful,
Bird Nick P.,
Matthews Julian,
Whitcher Brandon,
Nichols Thomas E.,
Lai Robert,
Lotay Narinder,
Saunders Ann,
Reiman Eric,
Chen Kewei,
Gold Mike,
Matthews Paul M.
Publication year - 2009
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2009.05.642
Subject(s) - rosiglitazone , posterior cingulate , medicine , placebo , positron emission tomography , alzheimer's disease , endocrinology , nuclear medicine , gastroenterology , pathology , disease , cognition , receptor , psychiatry , alternative medicine